Massachusetts Reaches $5 Billion Milestone in Marijuana Sales

Market by 2FIRSTS.ai
Sep.08.2023
Massachusetts Reaches $5 Billion Milestone in Marijuana Sales
Massachusetts has reached a milestone in marijuana sales, with total revenue surpassing $5 billion, setting monthly records in the process.

On September 8th, according to the American news website Marijuana Moment, the state of Massachusetts in the United States has achieved a significant milestone in marijuana sales, with total sales reaching $5 billion. At the same time, the state has also set consecutive monthly sales records.

 

The Cannabis Control Commission (CCC) in Massachusetts, United States, has announced that retail sales of adult-use marijuana have exceeded $5 billion since the state's recreational marijuana market launched five years ago.

 

After setting a record-breaking marijuana sales figure for three consecutive months from June to August, the total purchase amount in that state has now reached $5.02 billion. In August alone, sales reached $139.3 million, bringing the total sales for the first eight months of this year to $1.05 billion.

 

Since 2018, medical marijuana clinics have generated over $1.13 billion in sales, not only for recreational purposes but also for patients and caregivers.

 

In a press release, Shawn Collins, Executive Director of the CCC, stated,"Despite other states already starting to sell recreational marijuana, Massachusetts has still achieved record-breaking sales. In fact, our neighboring states of Maine, Rhode Island, and Connecticut have also seen record-breaking sales this summer."

 

Massachusetts reached a milestone in January this year, surpassing $4 billion in adult-use marijuana sales. In a remarkable feat, the state managed to add an additional $1 billion to this figure within a mere eight months, earning accolades for achieving the fastest ever $1 billion sales growth.

 

New state data from Massachusetts reveals that tax revenue generated from marijuana surpassed that of alcohol for the first time last year.

 

These record-breaking sales figures are particularly noteworthy as the recreational marijuana market is gradually emerging and expanding in nearby states such as Connecticut, Maryland, New York, and Rhode Island. This could potentially diminish purchases from out-of-state visitors.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
Exclusive | TPE 2026 Cools as Caution Deepens in the U.S. Vape Market
The show had become an important check-in point for Chinese manufacturers and brand owners looking for signs of change in the U.S. market after months of softer demand. Instead, participants said the event highlighted a more restrained mood: traffic in the vape section was uneven, standout launches were limited, and conversations often failed to turn into orders.
Special Report
Apr.12
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
Exclusive|Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes
Exclusive|Logistics Operators Warn of Possible New U.S. Border Crackdown on Illicit Vapes
Recent inspections and cargo disruption have led some logistics operators in the China-U.S. vape trade to see early signs of another U.S. border crackdown on illicit e-cigarettes. With late April to early May viewed as a key risk window, the market is watching closely. The bigger question is not only whether enforcement will tighten, but whether it can be sustained.
Special Report
Apr.09
 Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
Zyn Emerges as MAGA Cultural Symbol Amid FDA Policy Shift
According to The Wall Street Journal, nicotine pouch brand Zyn has rapidly gained popularity across the Trump administration and conservative political circles, including among U.S. Health Secretary Robert F. Kennedy Jr.
Business
May.20
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15